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Pre-Publication Draft 
The Early History of  
Medical Genetics in Canada 
Abstract: This article shows that the intellectual and specialist movements that supported the 
growth of medical genetics in Canada between 1947 and 1990 were emergent 
phenomena, created, split, and reattached to different groups of actors, and 
reconfigured numerous times over the course of four decades. In each instance, new 
kinds of working relationships appeared; sets of diverse actors in local university-
hospital settings coalesced into a new collectivity; and, as a collectivity, actors 
defined and/or redefined occupational roles and work rules. In its beginnings, 
medical genetics appears to be the object of a serious institutional manoeuver: a 
movement in support of the creation of examining and teaching positions in human 
genetics in North American medical schools. With time, the institutionalization of 
‘medical genetics’ took hold, spurred on by changes in the rate and direction of 
service delivery associated with genetic consultation and laboratory services in 
clinical settings. Medical genetics in Canada consequently gained a semblance of 
unanimity over its basic reference points and arrived at a meaning directly tributary to 
current acceptance of the term. 
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The history of genetics in medicine has mainly been examined in relation to eugenics in the first half 
of the twentieth century and to molecular biology in the final third. With regard to the former, the 
history of eugenics in Europe and North America has been well traversed by historians, and they 
have rightfully been critical of eugenic science and physician involvement in campaigns to sterilize, 
euthanise and otherwise breed out what were perceived to be ‘unfit’ or ‘degenerate’ elements in 
populations.1  In the latter case, by contrast, historians of molecular biology have produced excellent 
analyses of the discovery of DNA and the significance of subsequent efforts to map disease-causing 
genes.2  But what has been left out of the picture is the enormous amount of work that has gone into 
organising ‘medical genetics’.3 Accordingly, the focus of this article is on ways genetic techniques 
have been taken up in mainstream medicine and the circumstances under which the clinicians and 
scientists involved set about turning their work into a medical specialism. 
 Specifically, this article provides an overview of the history of medical genetics in Canada 
from the opening of the first genetic counselling clinic in 1947 to the recognition by the Royal 
College of Physicians and Surgeons (Canada) of medical genetics as a free-standing medical 
specialty in 1989. I argue that the case of medical genetics in Canada lends insight into the beguiling 
complementarity of contemporary genetic medicine that promotes, simultaneously, the need for a 
collective adjustment of the intuitions and principles of all health care providers to incorporate a 
genetic approach to medicine in their clinical practices and a new medical specialism (i.e., medical 
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genetics). The particular circumstances of the Canadian situation, I submit, throw highlight on the 
convoluted and circuitous inroads of genetics into medicine, from the early days of Mendelian-based 
approaches to explaining patterns of hereditary and familial disease to the contemporary networks of 
genetic care which span multiple areas of service delivery. It is noteworthy that Canada was among 
the first nations to develop multidisciplinary regional genetics centres with genetic counsellors, 
laboratory scientists and academic colleagues. Likewise, Canada was among the first nations to 
develop standards of service and training overseen and administered by a body of medical 
professionals: The Canadian College of Medical Geneticists. The College, established in 1976, 
preceded similar developments in the Netherlands, the United States, Finland, Sweden, Germany, 
France, and Denmark.  
I begin the article by providing a brief background for understanding the relationship between 
genetics and North American medicine. This includes an examination of how Canadian and 
American geneticists created an expert role for themselves in the universities and medical schools. 
By circa 1930, I note, geneticists were increasingly finding work as researchers and science 
professors in departments of zoology, botany, or biology. Discussions followed in the 1940s and 
1950s about a role for geneticists in clinical medicine performing teaching, research, and service 
functions. These discussions, I suggest, provided a framework for an understanding of medical 
genetics as applied human genetics. I then go on in the main section of the paper to show how 
Canadian geneticists, in a new role as experts, set out in the 1970s to establish standards of service 
delivery for multi-disciplinary centres providing genetic services. Services were assessed and 
configured to fit local health service requirements, most notably through the new policies and 
structures of the Canadian College of Medical Geneticists. 
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The Medico-Scientific Background of Medical Genetics in North America 
As early as 1814, in his Treatise on the Supposed Hereditary Properties of Diseases, the English 
physician Joseph Adams had accurately – from a genetics perspective – distinguished between 
familial diseases ‘confined to a single generation, to brothers and sisters, the children of the same 
parent’ and hereditary diseases which are ‘traced from generation to generation’.4 In addition, he 
identified congenital illness as ‘disease appearing at birth’, noting that such conditions are more 
frequently familial rather than hereditary. Causal explanations for these phenomena, nevertheless, 
were not available until the next century. It was not until the early twentieth century that genetic 
theories, based on experimental and statistical examination of the reappearance of visible differences 
between generations of individuals, were sufficiently mature to provide such explanations.  
The available evidence suggests that although the study of genetics gained acceptance 
between 1915 and 1930 in Norway, Sweden, Denmark, the United States and the Soviet Union, it 
was less well received in Germany, and quite poorly received in Britain and France.5 It was indeed 
the case that, although older life science programmes at American universities were dominated by 
traditional natural history foci, newer programmes were established after 1890 that were more likely 
to promote experimental research.6 New fields, such as genetics, which happened to be emerging in 
the midst of such growth, obtained the widest possible support by concentrating on the development 
of improved forms of pedigreed plants and animals.7 Little distinction was made in this context 
between what was then called ‘genetics’ and ‘practical breeding’.  
Experimental breeding initiatives started in the U.S. Department of Agriculture, state 
experimental stations, and under other public and private sponsorship.8 Certainly, before World War 
I, the agricultural connection provided geneticists with an institutional setting in which geneticists 
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could meet quasi-professionally and publish.9  Furthermore, the rapid expansion of agricultural 
research meant the supply of candidates in relevant applied sciences was insufficient to meet 
demand, and experimental station administrations began to hire individuals in the basic sciences – 
including genetics.10 After 1915, genetics in the United States ‘began to take the form of a sanctioned 
normative practice with its own well-defined methods and explanatory standards’.11 
Geneticists, nonetheless, worked predominantly in departments of zoology, botany, or 
biology, rather than departments of genetics or plant breeding.12 And interest in human genetics 
mainly collected on the periphery of eugenics and ‘practical breeding’, limited to a very small group 
of enthusiasts. Daniel J. Kevles indicates that fewer than two hundred people published any research 
in the early Anglo-North American contingent of human geneticists. Of these, fewer than fifty 
published more than once.13 The situation changed noticeably after World War II. Formal positions 
for ‘human’ geneticists were set up and implemented in twenty-nine multidisciplinary centres in the 
United States (twenty-five) and Canada (four).14 Ohio State University in 1933 had been the first site 
to require a course in human genetics as part of the medical school curriculum. Other centres doing 
research in human genetics followed in the 1940s: Bowman Gray School of Medicine (1940), 
University of Michigan (1941), University of Minnesota (1943), and University of Utah (1945). In 
addition, the Universities of Chicago, California, Oklahoma, Texas, and Toronto became centres for 
instruction, as well as Johns Hopkins, Duke, and Tulane. The data collected for the present study 
support earlier findings that many of the individuals involved in human genetics instruction in these 
centres not only voiced support for eugenics policies but also drew on eugenics societies and 
associations for resources for attendant ‘heredity counselling’.15 Counselling in this context 
originally referred to a loosely conceived set of activities associated with marriage and reproductive 
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advice. 
Very little is actually known about early attempts at human genetics instruction in North 
America. What we do know is that the Association of American Medical Colleges sponsored the first 
organised efforts to gather information on the extent of genetics instruction in American and 
Canadian medical schools. This began in 1946 with a survey that involved mailing questionnaires to 
eighty-four medical schools in the United States and Canada.16 It was found that seven schools 
provided formal courses in genetics, with an average of fifteen class hours of instruction. Lectures on 
genetics were given as part of other courses in twenty-five schools, with an average of five hours of 
classroom instruction. A second questionnaire survey, administered in 1953 by C. Nash Herndon, 
then director of the Department of Medical Genetics at Bowman-Gray School of Medicine, 
concluded that ‘there is no unanimity at present as to where genetic instruction really belongs in the 
medical curriculum’.17 By contrast, a 1954 report, based on a workshop of American and Canadian 
instructors, found unexpectedly high levels of support for genetics instruction in medical schools.18 
The report represents the first attempt to produce a blueprint for the future of medical genetics. 
Moreover, discussion generated by the recommendations of the report appears in a number of later 
surveys and reviews on the subject.19 Its discussions of ‘integrated curriculum’ and a role for 
geneticists in medical schools were certainly the first of their kind, and merit close examination. 
First of all, clinical methods involving the identification of hereditary factors in disease are 
described in the report as supplementing the practices of ‘any [medical] specialty that can be 
named’.20 Second, and concurrently, ‘genetics ... serves as a useful tool in the prevention of disease 
and limitation of disability’.21 Turning to the question of what to teach, the report recommends five 
fundamental areas of study for consideration: the physical basis for heredity (i.e., chromosomes); the 
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basic single gene mechanisms; interaction between heredity and environment; mutation and its 
evolutionary significance; knowledge of population genetics as well as instruction in the practice of 
genetic counselling. The authors suggest that these fundamentals can be covered adequately in 
twelve to fourteen hours of lectures, ‘if supplemented by a moderate amount of reading in available 
texts’.  
Furthermore, turning to the question of who should teach, participants in the workshop 
generally agreed upon ‘a trained medical geneticist on the staff’. 
He might be either an M.D. with special training in genetics, or a Ph.D. in human genetics with 
added training in the special applications of his subject to medical problems. Such a person could be 
attached to any department in accord with administrative convenience. He could function in several 
ways: he might teach the course or give the lectures on general principles in the second year. He 
could be used for integrated teaching in many areas, as for example in the problems of maternal-fetal 
immunologic incompatibilities, in connection with the teaching of metabolic diseases, anaemia, bone 
and eye diseases and in other areas.22 
 
The medical geneticist ‘could also have service and research functions’.23 Thus, a multi-faceted role 
was envisioned. As a ‘staff geneticist’ in teaching hospital settings, s/he would provide advisory 
services, on the one hand, in family counselling directly with consultants, and, on the other, to 
practitioners and researchers requiring consultation in cases involving complex genetic problems. 
As noted above, the recommendations of the 1954 AAMC report enjoyed considerable 
support and further discussion in subsequent surveys and reviews. Comparatively speaking, five 
surveys show that the proportion of medical schools with formal courses in genetics increased 
from 8.6 per cent in 1953 to 86.5 per cent in 1985.24  However, three surveys indicate that, rather 
than an integrated curriculum, genetics instruction increasingly became the preserve of 
paediatricians and geneticists teaching in independent genetics departments. This issue went on 
to be described in reviews and surveys as an interdisciplinary ‘problem’; a problem frustrating 
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the larger goal ‘that “genetically thinking” becomes an integral part of [all] medical practice’.25 
From this emerged what I have called elsewhere a bifurcated ideological construct26 that shaped 
and informed the means of organising a ‘genetics-based approach’ to medicine.27 The construct 
stipulated, on the one hand, that the mandate of medical genetics was to add a new set of medical 
procedures to the clinical repertoire of all individuals trained as physicians. On the other hand, it 
indicated that when and where physicians were unable to provide the new procedures, a class of 
specialists (i.e., medical geneticists) would be available for consultation. Accordingly, Vincent 
M. Riccardi, a consultant working in the Neurofibromatosis Program at Baylor College of 
Medicine, professed: 
... it is incumbent on clinicians in all health care disciplines to recognize when health impairment 
is due, in part or in whole, to a genetic cause. All clinicians must be able to determine whether a 
given disorder is genetic, possibly genetic, or not genetic, and be able to share that information 
with the patient or family and refer them, if necessary, to specialists for further assistance. ... 
Ensuring that a family with a genetic disorder receives genetic counselling is a primary 
care responsibility, even though the actual genetic counselling may be carried out by a specialist 
in a secondary or tertiary care facility. 28 (Emphasis in the original) 
 
Medical Genetics: The Canadian Case29 
The beginnings of medical genetics in Canada have been reported by others in relation to the coinage 
of the field’s name in 1932 by Madge Thurlow Macklin, then at the University of Western Ontario,30 
and  in the formation of the first Canadian heredity counselling clinic at the (Toronto) Hospital for 
Sick Children in 1947 by Alan Brown and Norma Ford Walker.31 The institutionalisation of medical 
genetics as a medical specialism in Canada, however, has not been examined. 
 Fiona Miller’s study of early developments in Toronto has thrown highlight on Norma Ford 
Walker’s accomplishments in the field of dermatoglyphic pattern analysis.32 Indeed, following the 
discovery of the chromosomal basis of Down’s syndrome in 1959, scientific interest in dermal 
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patterns intensified, and pattern analysis was recognized as a useful method for diagnosing patients 
for chromosome analysis.33 But what is problematic here is Miller’s claim that Walker’s research 
was ‘marginal’ and that she was involved in establishing some kind of a ‘school’ of medical 
genetics. In actuality, Norma Ford Walker had little interest in medicine per se.34 Trained as an 
invertebrate zoologist at the University of Toronto; she gained considerable notoriety in science 
circles for her work on the dermatoglyphics of the Dionne quintuplets, the first quintuplets known to 
survive infancy.35  
Contrary to Miller’s characterisation of this work as ‘iconoclastic genetics’ and ‘marginal’, 
the study of the quintuplets completed in 1937 was a significant contribution to contemporary studies 
of ‘mental likeness’ in twins and intelligence testing.36 The importance of twin studies, especially 
monozygotic twins (i.e., from ‘one egg’, identical) and reared together, was widely viewed as proof 
positive of the perdurability of human nature.37 More particularly, the Dionne study lent credible 
support for Gesell’s proposition that even the most identical twins had inbred differences that could 
become more or less profound according to motor training and mental stimulation.38 
 Norma Ford Walker’s subsequent appointment as a genetics consultant in 1940 by Alan 
Brown, chief of paediatrics at the (Toronto) Hospital for Sick Children, entailed a kind of exchange 
relationship: Hospital clinicians would send patients and families to her. She would calculate 
patterns of hereditary transmission and counsel the families on issues relevant to family planning and 
the recurrence of familial traits. In return, she was permitted to freely pursue her own research 
interests, along with those of her students, in the hospital. It is important to note, however, that the 
hospital’s arrangements for Walker’s services never included laboratory supports. Thus, Louis 
Siminovitch, appointed Geneticist-in-Chief to the Hospital for Sick Children in 1968, encountered a 
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fragmented set of service operations that had failed to keep pace with other multidisciplinary centres 
in North America.39 In actuality, a fully integrated Division of Clinical Genetics, jointly responsible 
to the Department of Genetics and the Department of Paediatrics, did not appear until 1986. 
 Cumulative links between genetics and specialised areas of medical research and services 
can be studied more easily in developments at McGill University in Montreal. The interwar years 
saw well-known figures such as the English hereditarian H. B. Fantam as McGill’s Strathcoma 
Professor of Zoology, and a brief stint of teaching by Lancelot Hogben, who went on to become 
professor of social biology at the London School of Economics. In 1934 an independent 
department of genetics was formed. There had been disagreement at the university level between 
the departments of zoology and botany about who should teach undergraduate genetics. The 
dispute was resolved by way of receiving a Rockefeller Foundation grant to start up an 
independent genetics department. The first chair was C. Leonard Huskins, a plant geneticist who 
also consulted with local physicians on Mendelian disorders. In 1949, F. Clarke Fraser, a PhD-
geneticist in his final year of medical school, was asked to set up a genetic counselling service at 
the Montreal Children’s Hospital. This came as a result of negotiations between J. Wallace 
Boyes, Huskins’s successor at McGill, and Alton Goldbloom, the hospital’s chief of paediatrics. 
A department of medical genetics was formally approved at the hospital in 1951, with a staff 
consisting of Fraser and an assistant. Fraser recalled the casual attitude shown toward counselling 
services in an interview: 
When I started genetic counselling, it was essentially a physician calling you up and saying: ‘I’ve got 
this mother who has a haemophiliac baby. What’s the chance of recurrence?’ And I would look it up 
and tell them. Then I began to see families in person, take family histories, and do the counselling 
myself.... I used to walk down the ward and look down the list of patients and see if anything 
genetically interesting was on the ward and then quiz the residents on recurrence risks. And 
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gradually, I got the reputation for being useful, now and then. And so genetics began gradually to be 
recognized around the hospital. But this was very new for Canada.40 
 
Developments of the sort described above at Toronto and Montreal can reasonably be viewed 
as starting points for later developments in Canada. Of the fifteen sites in Canada that presently 
provide some combination of medical genetics training and services, eight (Edmonton, Vancouver, 
Winnipeg, London, Montreal [Ste-Justine], Quebec City, Hamilton, Kingston) were set up by 
individuals who had studied in Toronto and Montreal. The remaining five sites (Saskatoon, Ottawa, 
Halifax, Calgary, St. John’s) were set up by individuals who originally trained in the UK (four MDs, 
one PhD, one PhD/MD). Only two of these received training in genetics in the UK, however. One 
trained in Canada, another in the United States, and a third ‘picked it up on the job’. Thus, Toronto 
and Montreal figure into the story of medical genetics in Canada as key sites of information 
exchange and genetics training. But, then again, this was a period when there were few referrals of 
patients for genetic counselling. The exchange of information about genetics was pursued largely in 
terms of teaching and research interests by individuals who only provided counselling when called 
upon to do so. What’s more, one has to consider how important links with the United States were for 
collegial support and approbation. 
Diane B. Paul and Daniel Kevles have indicated that in the two decades following the 
Second World War ‘virtually all institutional patrons [in the United States] of work in medical 
genetics and genetic counseling also had eugenic motivations’.41 Specifically, attention is drawn 
to support from the Rockefeller, Carnegie, Wenner-Grenn, McGregor, and Rackham foundations, 
the Commonwealth and Pioneer Funds, and the American Eugenics Society.42 Canadian 
geneticists, by contrast, did not enjoy this kind of support during this period. As noted above, the 
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genetics department at McGill had received some start-up funding from the Rockefeller 
Foundation. But this was the exception.  
As Angus McLaren has shown, the establishment of eugenics institutions like the 
Eugenics Society of Canada came about relatively late in comparison to developments in the 
United States.43 Eugenics policies were successfully enacted in the provinces of British Columbia 
and Ontario in favour of segregating ‘mentally defective’ school children.44 Eugenics sterilization 
laws were enacted in Alberta and British Columbia.45 But the physicians who were active in the 
eugenics programmes came from the field of public health – not genetics research or clinical 
medicine.46 Early financial support for genetic counselling services came through hospital 
budgets or was divested from funds earmarked for research.47 
 It was the American Society of Human Genetics, established in 1949, which provided 
Canadian geneticists with opportunities to meet and exchange information with like-minded fellows 
on an intra-continental level. The idea for the Society was proposed at an informal gathering in 
December 1947 held during the meetings of the American Association for the Advancement of 
Science at Chicago. The early meetings were tiny and, initially, it was difficult to attract articles to 
publish in its journal, the American Journal of Human Genetics. But within five years the 
membership had grown to 565 individuals with 316 institutional subscribers to the journal.48 
Americans made up 84 per cent of the membership at the time. Of the remaining 16 per cent, 5 per 
cent were Canadians. That said, of the 27 Canadian members, 25 were from Ontario and Quebec. 
And 14 of these individuals were affiliated with the University of Toronto (9) and McGill (5). 
Moreover, from the start, Canadians served as directors of the Society and editors of the journal. 
From the perspective of the present study, the American Society of Human Genetics is 
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especially important for the ideological stance it took. The first president, Hermann J. Muller, a 
Nobel prize laureate at Indiana University well known for his discovery of artificially induced 
mutations in genes, observed: 
Included in the ranks of our present group there are many persons of genetic competence who are 
primarily medical men, of varied specialties, there are some genetically qualified anthropologists, 
psychologists and students of social sciences, and there is a good share of persons whose main field 
is genetics itself but who have acquired a considerable interest in and knowledge of one or more of 
the specifically human subjects. Our board of directors and our editorial staff have been chosen so as 
to represent all these groups. We hope to therefore be able to avoid that dilettantism which has in the 
past characterized so many attempts to study human hereditary. … 
… It happens that the prolonged delay in setting up the present working association has one 
very fortunate aspect. This derives from the fact that, until very recent years, the subject of human 
heredity was buffeted about by pressure groups from the extreme political right and left, who sought 
to impose their social preconceptions in the form of a spurious ‘nature-nurture controversy’, in which 
the methods of objective science were largely forgotten. The development of a more scientifically 
minded group of students of the subject has required the influence of basic genetics, working over 
many years. And in recent years, this sounder attitude has been reinforced by the lessons of the 
terrible mistakes made by the political protagonists of fascism and communism, respectively, when 
they gained the power to translate their biological prejudices into action.49  
 
These observations reflect turning points in the development of both human genetics and medical 
genetics. The geneticists, who now had the sense of security that comes with permanent university 
posts, became increasingly vocal in their disdain for the pseudo-science of amateurs – what Muller 
was calling ‘that dilettantism.’50  
A wholesale shift in the meaning of ‘eugenics’ followed along the lines of certain 
irreconcilable differences between the ameliorism of the eugenic practices and what was being 
presented as the value-free science of human genetics. This shift found its expression most forcefully 
in what Sheldon C. Reed, director of the Dight Institute of Human Genetics, called ‘non-directive 
genetic counselling’; a procedure intended to explain to patients ‘what the genetic situation is … but 
the decision must be a personal one between the husband and wife, and theirs alone’.51 
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Non-directive genetic counselling, in the context of a medical service provided by staff 
geneticists (à la the 1954 American Association of Medical College report), would emphasize a 
‘scientific basis for the concepts of individuality and variation within the species.’52 ‘Pathologic 
genes’ were themselves to be viewed as ‘etiologic agents of disease’; agents that, with time, would 
account for an increasing proportion of the clinician’s workload. Hence, James V. Neel, director of 
the Heredity Clinic at the University of Michigan, predicted: 
In the year 1900, pneumonia, influenza, tuberculosis, diarrhea, diphtheria and typhoid fever 
accounted for 610.9 deaths among each 100,000 inhabitants of the United States. In the year 
1947 … these same diseases were responsible for only 78.0 deaths per 100,000 population. It 
may confidently be anticipated that in another ten years, when the full impact of the recent rain of 
antibiotics has been realized, those diseases will account for no more than 30 to 40 deaths per 
100,000. … 
… The result of this rapid disappearance of the infectious and contagious diseases from the 
medical scene has, of course, been, and to an increasing extent will be, the direction of medical 
attention towards conditions variously and overlappingly termed constitutional, endocrine, 
metabolic, or congenital. It is in the etiology of just these conditions that the role of genetic 
factors is most evident. A working knowledge of the elementary principles of genetics is thus in 
many instances indispensable to the formulation of a well rounded picture of a given disease.53 
 
Additionally, non-directive genetic counselling would conform to evolving medico-legal 
norms that served to increase patient autonomy over physician beneficence. There were ongoing 
debates about physicians’ freedoms of decision-making in the years following the revelations of 
Nazi atrocities at the Nuremberg Trials.54  These freedoms, many argued, should be governed by 
a fiduciary duty of respect for patient autonomy that stressed non-interference. A principle 
emerged that ‘every human being of adult years and sound mind has the right to determine what 
shall be done with his own body’. Genetic counselling was, consequently, to be viewed in terms 
of a contract for services and the essence of the physician-patient relationship would be 
transformed from one of status to one of contract.  
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Importantly, the movement to formally standardise genetic counselling services was 
subsequently linked to changes in the clinical division of labour, changes that were integrally linked 
to the development of new diagnostic tests and laboratory services in the 1960s and 1970s. The first 
development involved the investigation of chromosomal abnormalities. Human chromosomal 
analysis in the 1950s and 1960s involved techniques largely developed in cytological studies of 
animal and plant species carried out in the 1920s and 1930s.55 Improved methods during this period 
made it easier to count human chromosomes and to study their morphology. This, in turn, permitted 
some types of chromosomal abnormalities, including missing or extra copies of a chromosome or 
gross breaks and rejoinings (translocations), to be detected by microscopic examination. The 
presence of an additional small acrocentric chromosome in typical cases of Down’s syndrome was 
first reported in France by Jérôme Lejeune, Marthe Gauthier and Raymond Turpin in 1959.56 This 
was quickly followed by reports from cytological laboratories in England.57 The publication of these 
findings in quick succession during 1959 caused a sensation among scientists and clinicians alike. 
The development of human cytological genetics or ‘cytogenetics’ provided clinical tools to uncover 
the genetical make-up of relatively common disorders. And it is important here to stress the novelty 
of cytogenetics during this period. Chromosomal abnormalities were mostly of unknown aetiology 
and this was a time of uncertainty concerning the precise relationship of congenital and hereditary 
disease. What mattered was something new: the chromosomal bases of diseases. 
While the Europeans were working out techniques to count human chromosomes, Murray 
Barr and Canadian colleagues at the University of Western Ontario were studying sexual dimorphism 
at the cellular level by observing and describing the sex chromatin body in the neuronal nuclei of 
female cats and its absence in male cats.58 The clinical possibilities of Barr’s cytogenetic laboratory 
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were pursued by Howard Valentine, a professor in the Department of Paediatrics in the late 1950s. 
He recalled in an interview: 
When the sex chromatin business broke, I kind of heard about it, but that didn’t particularly interest 
me because the sex chromosomes weren’t really all that connected with paediatric disorders. At least 
they weren’t recognized as such at that time. Turner syndrome and the XO sex chromosome 
complement was kind of recognized as a clinical entity among the paediatricians ... but in general it 
wasn’t until Down’s syndrome was recognized as being a chromosomal abnormality that I really 
became interested in cytogenetics. And then I read Murray Barr’s work and I got interested in further 
developments of cytogenetics because of Down’s syndrome, which was an interest of mine even 
before cytogenetics was invented. I had been puzzled and interested in Down’s syndrome. And then 
when Down’s syndrome broke, and it was recognized that this was a cytogenetic abnormality, then 
that fired up my interest. Then I teamed up with Fred Sergovich, who … was a graduate student of 
Murray Barr’s, who went to work on the cytogenetics of Down syndrome.59 
 
Meanwhile, interest in cytogenetics in Quebec was stimulated by the discoveries of 
Jérôme Lejeune and colleagues in France. Lejeune announced the discovery of trisomy 21 and 
Down’s syndrome at a seminar in the McGill University genetics department in 1958, following 
the International Genetics Congress at Montreal that summer. Jacques Gagnon, a pathologist at 
Université de Montréal, went to study with Lejeune in France and then brought cytogenetics back 
to Montreal at l’Hôpital Ste-Justine in 1959. Cytogenetics was established at McGill the 
following year when Louis Dallaire set up a laboratory to study chromosomal translocations for 
his PhD research under the supervision of Clarke Fraser. Fraser, who was also the geneticist on 
staff at the Montreal Children’s Hospital, subsequently asked Dallaire to develop a service 
laboratory for the hospital in 1964. &&&A succession of regional cytogenetic services quickly 
followed in other provincial centres: University of Alberta Hospital at Edmonton (1962); 
Department of Paediatrics, University of Saskatchewan at Saskatoon (1964); Ottawa Civic 
Hospital (1965); Department of Pathology, Queen’s University at Kingston (1968); Children’s 
Hospital of Manitoba at Winnipeg (1969); Foothills Hospital at Calgary (1969); and Izaak 
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Walton Killam Hospital at Halifax (1970).  
The problem of transporting diagnostic test samples from disparate locations in the 
Canadian provinces presented a huge challenge for geneticists running laboratories in hospitals 
that were largely situated close to the American border.60 Plant cytologists and other technical 
staff were recruited to perform a service function in chromosome laboratories,’ and a new 
occupational category was created, ‘cytogeneticists’.61  A laboratory testing protocol was devised 
whereby physicians communicated by telephone suspected cases of chromosomal abnormality to 
either staff geneticists or cytogeneticists in regional centres. If it appeared that a chromosomal 
analysis was in order, a test kit was dispatched, usually by bus, to the consulting physician. The 
physician drew blood from the patient, mixed test samples with the culture media supplied, and 
then shipped everything back to the laboratory. A cytogeneticist’s report was then prepared for 
the consulting physician. 
Biochemical testing, a parallel development to chromosome analysis, involves 
biochemical demonstration of abnormal metabolites in body fluids. Biochemical analysis is 
useful in cases where the products (i.e., end results) of an abnormal gene are present. 
Monogenetic gene mutations may either block the synthesis of certain enzymes or lead to the 
production of enzymes with abnormal structures. In either situation, metabolic processes are 
disrupted. After 1960, the basic division of labour involved in biochemical testing followed a 
pattern similar to that of chromosome analysis: individuals with backgrounds in chemistry were 
recruited to perform a service function in ‘biochemical laboratories’, and a new occupational 
category appeared, ‘biochemical geneticists’.62 Physicians would look for tell-tale signs and 
symptoms (e.g., failure to thrive, developmental delay, ocular abnormalities) that might be 
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indicative of a metabolic disease. A geneticist would be consulted regarding the family history 
and, if a laboratory evaluation was in order, blood or urine was obtained and shipped to the 
laboratory where it would undergo chemical testing. A laboratory report would be returned to the 
consulting physician with information about a geneticist who was available for consultation. 
The movement to introduce newborn screening programs in the provinces began when a 
simple and inexpensive metabolite inhibition assay was developed in the United States to detect a 
treatable metabolic disease.63 The test, combined with a treatment (dietary phenylalanine 
restriction), had led to a highly successful therapy for phenylketonuria. Therapeutic and/or 
curative interventions followed for galactosaemia, congenital hypothyroidism, 
aminoacidopathies, fructose intolerance, tyrosinaemia, and other metabolic conditions.64 Between 
1963 and 1969, newborn screening programs were subsequently set up in nine provinces largely 
administered through provincial public health programmes. The first was established in 1963 in 
Prince Edward Island. Programs followed in British Columbia in 1964; Saskatchewan, Manitoba, 
and Ontario in 1965; New Brunswick and Nova Scotia in 1966; and Alberta and Quebec in 1969. 
Only in Quebec did geneticists take a proactive role in the organization of a province-wide 
program. 
Le Réseau de la Médecine Génétique du Québec was formed in October 1969 on the 
recommendation of four heads of the paediatrics departments at the Centre Hospitalier 
Universitaire de Laval, Le Centre Hospitalier Universitaire de Sherbrooke, the Montreal 
Children’s Hospital and l’Hôpital Ste-Justine. The network began receiving provincial funding 
that year, and incorporated itself as Le Réseau Provincial de la Médecine Génétique du Québec 
in 1971. The mandate of the Réseau, firstly, was to develop a centralized program for the early 
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detection of metabolic diseases in newborns. It did so by coordinating resources in the four 
hospitals. Additionally, it held a mandate to do research and development in the area of genetic 
services. By the mid-1970s, the Réseau provided diagnostic services, counselling and treatment 
for approximately thirty metabolic disorders.  
Screening programs in the other provinces emerged as independent provincial ministry of 
health programs.65 But, despite the fact that screening came under the purview of public health 
branches and departments of health and community services, the genetics centres provided the 
laboratory and counselling services. A service protocol was devised in which a staff member of 
either a public health unit or a genetics clinic would review the hospital lists of newborns and 
ensure that blood samples were taken. An attending physician receiving a positive test report had 
the option of either counselling the family him- or herself, or utilizing the services of the regional 
genetics centre.  
Further to the new diagnostic test regimes of the 1960s, geneticists experienced increases 
in workload after 1970 with the work associated with prenatal diagnosis. Refined techniques for 
culturing foetal cells from amniotic fluid were developed and amniocentesis became useful as an 
outpatient procedure for obtaining test samples for chromosomal and biochemical analysis. 
Obstetricians performed all the amniocentesis procedures. This involved removing amniotic fluid 
during early pregnancy by puncturing the amniotic sac with an aspiration needle – a procedure 
with risks to the mother, including bleeding and infections, and to the foetus, including needle 
puncture, premature labour, and, potentially, spontaneous abortion. If the amniocentesis was 
performed in a genetics centre, geneticists provided pre-procedure counselling to inform the 
patient of the risks associated with the procedure. The geneticists would also schedule when and 
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where the procedure was offered. Moreover, the geneticists would review test results and provide 
counselling in the event of a positive result. 
The first concerted effort to monitor the rate and direction of genetic services was 
mounted in the early 1970s when geneticists realised that they were spending proportionally less 
time in the classrooms and labs and more time in the clinics. Members of the Genetics Society of 
Canada established a committee in 1971, the Committee on Genetics as it Relates to Social 
Problems, with a mandate to examine standards of care, payment for services rendered, and the 
accreditation of individuals offering genetic counselling. A survey by questionnaire of twenty-
two individuals known to be providing genetic services in thirteen cities (Toronto, Montreal, 
Quebec City, Vancouver, Victoria, Ottawa, Kingston, London, Hamilton, Winnipeg, Edmonton, 
Saskatoon, Halifax) confirmed that an increase in demand for genetic counseling had occurred 
and attributed the increase to innovations in laboratory and obstetric services.66 The survey 
showed that the costs of laboratory services were was not directly reimbursed through provincial 
health care insurance schemes. Costs were largely paid for with research funds, or were being 
absorbed through hospital global budgets. 
The problems identified in the survey were made the focus of an informal meeting two years 
later that was organized as part of the 1973 annual conference of the Genetics Society of Canada in 
North York, Ontario at York University. It was here that the idea of creating a formal mechanism to 
maintain standards of genetic services first surfaced. In a statement prepared by the Committee on 
Genetics as it Relates to Social Problems, and approved by the Genetics Society of Canada 
Executive, a recommendation was made that the Society lobby the appropriate federal and provincial 
government authorities, first, to acknowledge genetic counselling was an important health service, 
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and, second, to develop a means of accrediting the centres offering services.67 Further to this, multi-
disciplinary centres were described that would integrate PhD-geneticists (i.e., non-physicians) into 
clinical practice. Interviewees for the present study who participated in the meeting said that they 
were deliberately trying to topple restrictions surrounding who and who could not provide patient 
care. What emerged from all this was a coalition to form a corporation to be known as the Canadian 
College of Medical Geneticists.68 
A proposal to create the Canadian College of Medical Geneticists was presented to an 
assembly of thirty-three individuals who were invited to attend a three-day meeting at the Guild Inn 
in Scarborough, Ontario in November of 1974. All attendees were providers of genetic services and 
nine provinces were represented. The proposal was accepted, and a steering committee was elected 
to make an application for incorporation and draw up a constitution and by-laws for the new College. 
A statement from the Steering Committee followed in the April 1975 issue of The Genetics Society 
of Canada Bulletin declaring the proposed College was ‘not a scientific society such as the Genetics 
Society of Canada, but an organization concerned with the establishment and enforcement of 
professional standards on health care delivery in the field of Medical Genetics’.69 Later statements 
asserted that the College would consist of and represent ‘those properly qualified PhDs and MDs’ 
and affirmed ‘that individuals with a PhD have a role to play in delivering genetic services’. The 
delivery of services would be associated with medical centres where physicians trained in medical 
genetics would provide patient consultation. The centre would assume responsibility for monitoring 
the quality of the laboratory services and accreditation evaluations would be formulated by the 
Canadian College of Medical Geneticists.70 
The first meeting of the newly-formed Board of Directors took place at the Club Saint-Denis 
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in Montreal on November 3, 1975. The application for the incorporation of the College was recorded 
by the Ministry of Consumer and Corporate Affairs on January 13, 1976. The initial focus was on 
recruiting as members a fair representation of individuals in active clinical practice. A special 
dispensation was devised to ‘grandparent’ individuals deemed to already possess sufficient 
knowledge and skills to be considered Fellows of the College.71 Additionally, in 1976, the Board 
courted controversy by submitting a proposal to the Royal College of Physicians and Surgeons 
(Canada) requesting the formation of a sub-specialty in medical genetics. Despite the concern of 
many members that PhD-geneticists might get left behind if such an application were accepted, the 
College of Medical Geneticists and the Royal College pursued a series of negotiations over the next 
decade that would ultimately change the course of delivering genetic services in Canada.  
Before turning to the substance of the negotiations surrounding specialty formation, some 
background about the Royal College is necessary. Incorporated by Act of Parliament and receiving 
Royal Assent in June of 1929, the Royal College has had no medical licensing powers per se.72 An 
official invitation for the Royal College to establish the certification of specialists was received from 
the Canadian Medical Association in 1937, and a joint committee of the Association and Royal 
College was formed. Subsequent relations between the Royal College and would-be specialists 
would focus on, first, determining requirements and standards of training, and, second, conducting 
examinations for specialist certification. A committee structure was created comprised of sub-
committees made up of individuals representing independent specialties or sub-specialties. 
Between 1930 and 1947, the number of specialties that the Royal College recognized 
increased from two to twenty-one.73 There then followed a fifteen-year period in which further 
recognition was not granted. A second wave of specialty formation occurred between 1964 and 1974, 
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with a total of thirteen new specialist sub-committees being admitted to the Royal College’s Division 
of Medicine. Concerned about the rapid proliferation of specialties, the Council of the Royal College 
acted in 1974 on a recommendation to declare a moratorium on the recognition of new specialties – a 
course of action that had been taken earlier by the American Board of Medical Specialties under 
similar circumstances. New policies followed with, on the one hand, a set of guidelines for defining 
specialty areas, and, on the other, a new Certificate of Special Competence to signify recognition of a 
sub-specialty subordinate to certification in a primary specialty. With regard to the latter, it was 
suggested that the Certificate might obviate the need to recognize new specialties and alleviate 
concerns about the fragmentation of the medical profession.  
The moratorium was in effect lifted in January 1975 when Council approved the recognition 
of paediatric general surgery as a specialty by means of a Certificate of Special Competence. Primary 
certification soon followed in geriatric medicine, nephrology, thoracic surgery, and perinatal 
medicine. Partial recognition (i.e., a certificate of special competence in medical genetics) was 
granted in 1979 to medical genetics, but owing to differences with the Canadian College of Medical 
Geneticists, the Royal College suspended the implementation of the recognition. 
As noted above, the Canadian College of Medical Geneticists had made an application for 
recognition as a specialty in 1976. Correspondence, initiated by the Board of Directors, was referred 
to the Royal College’s Committee on Specialty Development, and informal contacts were made. 
Meetings followed between the Committee and members of the Canadian College of Medical 
Geneticists over a three-year period to explore the possibility of a certificate of special competence 
or, alternatively, a free-standing specialty in medical genetics. Based on what interviewees recalled 
about the tone of the negotiations, it appears that the Royal College’s Committee on Specialty 
  24 
Development followed closely the 1975 guidelines on specialty recognition. In May of 1978 the 
geneticists provided to the Committee on Specialty Development a brief consisting of reasons why 
medical genetics constituted a separate body of medical knowledge; a proposal for specialty training 
in medical genetics; and up-dated lists of the names, credentials and places of work of College 
fellows, Board directors, and members of the six standing committees of the College. In addition, the 
brief specified that medical genetics had already been recognized as a medical specialty in the 
Province of Saskatchewan and that the majority of all medical geneticists currently practicing and 
teaching in Canada were members of the College. Further to this, it indicated that the American 
College of Medical Geneticists currently in formation was modelled on the Canadian College of 
Medical Geneticists. 
In 1981, the College formally declined an offer made by the Royal College to grant a 
certificate of special competence in medical genetics to Fellows of the Royal College certified in 
either paediatrics or internal medicine as their primary certification. However, members continued to 
talk informally to individuals on the Royal College’s Committee on Specialty Development while, 
simultaneously, making inquiries with the provincial licensing bodies about the Canadian College of 
Medical Geneticists becoming some kind of national accrediting body. These groups were generally 
unresponsive, but at another level, the College was successful. By the early 1980s, interviewees for 
the present study recalled a substantial portion of postings for medical genetics positions in Canada 
requiring prospective candidates to have either passed or be eligible to take the College’s written and 
oral examinations. 
It was not until 1988 that the Specialty and Manpower Committee of the Royal College 
supported the creation of a free-standing specialty with a five-year training program. The 
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recommendation was approved by the Credentials Committee and Royal College’s Council so that, 
in 1989, medical genetics attained status as one of fourteen clinical specialties recognized by the 
Royal College’s Division of Medicine. By the time Canadian medical geneticists had gained 
specialty recognition from the Royal College there were eighteen centres in eight provinces that 
provided counselling and laboratory services. All belonged to university-hospital affiliated programs, 
with the exception of three centres in Ontario. In addition, nine provinces had established outreach 
programs whereby staff from genetics centres was dispatched on a regular basis to hold clinics sites 
in outlying areas. 
Of the sixteen Canadian universities with faculties of medicine, seven offered Royal College 
accredited residency training programs in medical genetics, and seven offered training programs 
accredited by the Canadian College of Medical Geneticists. Within the overall range of programs, 
those designated ‘medical genetics’ with Royal College accreditation were separable from programs 
in ‘clinical genetics’, ‘cytogenetics’, ‘biochemical genetics’, and ‘molecular genetics’ accredited by 
the Canadian College of Medical Geneticists. Additionally, the Canadian College of Medical 
Geneticists issued certificates in four other categories to successful applicants with MD or PhD 
degrees: medical genetics, cytogenetics, biochemical genetics, and molecular genetics. In practical 
terms, this meant that holders of MD degrees could either apply for certification as medical genetics 
specialists after completing a defined period of specialty residency in a program recognized by the 
Royal College, or, after obtaining certification as specialists in another area of practice recognized 
by the Royal College, apply for certification as clinical geneticists recognized by the Canadian 
College of Medical Geneticists. Holders of PhD degrees could only apply for Canadian College of 
Medical Geneticists certification. Ten years after specialty recognition, only two clinical geneticists 
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were employed in provincial genetics centres with just Royal College training in medical genetics. At 
the same time, a healthy percentage (forty four per cent) of the MD-geneticists was certified by both 
bodies, indicating a relatively high level of acceptance in the field for the RCPSC medical geneticist 
category. The other fifty three per cent of clinicians providing counselling and consultation in 
genetics centres, by contrast, were made up of individuals who had entered the field prior to 1989.  
As a final point, it is worth noting that the role of MD-geneticists evolved in relation to the 
roles of other medical specialists. In brief, two broad sets of activities can be identified. The first set 
falls under a general category of prenatal care in pregnancy and childbirth, and overlaps with the 
services of obstetrics and gynaecology. Activities in this set continue to be referred to by their 
function: ‘prenatal diagnosis’. This can be distinguished from what is called ‘general genetics’. 
General genetics is a catch-all category for activities involving infants, children and adults. As a set 
of activities unto itself, it can be further divided into three subsets. Activities in the first subset 
overlap with the area of neonatology. This involves the diagnosis and management of congenital 
anomalies and diseases in newborns. The second subset takes up broader paediatric concerns and 
focuses on the diagnosis and management of disorders in children.  Finally, the third subset deals 
with adult-onset diseases and screening for carriers of heritable conditions. In this regard, the nature 
of the interface with other specialists shifts paradigmatically depending on whether the patient is a 
pregnant woman, an infant, a child, or an adult. 
Concluding Observations 
The history of Canadian medical geneticists outlined in this article describes, first, early efforts in 
collaboration with American geneticists to create examining and teaching positions in medical 
schools for human genetics instruction and, secondly, independent efforts to create a new medical 
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specialty. With regard to the former, early discussions of an ‘integrated curriculum’ and a role for 
geneticists in medicine envisioned teaching, research, and service functions. In the 1940s and 1950s, 
the role of the medical geneticist emphasized teaching and research tasks in medical academia. 
Referral for genetic consultation was based largely on personal reputations for specialized knowledge 
and scientific expertise. And medical faculties in universities served as centres where new skills 
could be developed and knowledge and information exchanged.  
Circumstances changed in the 1960s and 1970s. The clinical possibilities of technological 
advances in the form of new laboratory technologies for identifying chromosomal anomalies and 
genetic metabolic disease were quickly recognized. Demand for genetic advisory services increased, 
and the geneticists, in turn, moved to establish standards of practice and lay the groundwork for the 
division of labour we see in Canadian genetics centres today. This last aspect is especially important 
as regards what it now means to be a medical geneticist. The principal selective mechanism to 
maintain the collective identity of geneticists as medical specialists is the division of labour, which at 
once differentiates them from other specialized workers in medicine (e.g., laboratory workers, 
scientists, other medical specialists).  
However, in addition, significant questions can be raised for future consideration and 
historical inquiry. The material presented in this article shows how occupational specialization in the 
broader field of genetics and medicine underwent remarkable divarication in a relatively short period 
of time. Moreover, it shows that the role of the geneticist in medicine evolved to a point where 
interchangeability between clinical- and laboratory-based functions abated. So, how will medical 
genetics as a free-standing medical specialty maintain itself as a specialty area? Are there sufficient 
resources and infrastructure to encourage an ongoing sense of collective identity of medical 
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geneticists as medical specialists? And, should there occur a lack of supports internal to medical 
genetics to encourage stability and foster growth, will there be external factors to do so, e.g., 
monetary gains, collegial approbation, patient demand, public policies?  
Additionally, we are seeing more and more diagnostic tests as a result of the ‘genomics 
revolution’ that are adding to the clinician’s ‘toolbox’. Increasingly it is the case that clinicians who 
hold specialist qualifications in a specialty outside of medical genetics are presenting themselves as 
experts on the genetics of a particular illness or illness group. Might the activities of these other 
medical specialists, then, reduce demand for the services of medical geneticists? Can we say that the 
relationship between genetics and medicine is evolving and unfolding over time in a variety of 
clinical settings? If so, there then follows yet another question: How will specialists – medical 
geneticists and otherwise – keep (or be kept) abreast of scientific developments in genetics? 
Moreover, can any specialist afford not to keep abreast of these developments?  
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